Maxim Group Issues Pessimistic Forecast for Cryo-Cell International (NYSEAMERICAN:CCEL) Stock Price

Cryo-Cell International (NYSEAMERICAN:CCEL) had its price target reduced by equities researchers at Maxim Group from $9.00 to $8.50 in a report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Maxim Group’s price objective indicates a potential upside of 28.79% from the stock’s current price.

Cryo-Cell International Stock Down 1.8 %

NYSEAMERICAN CCEL traded down $0.12 during trading on Tuesday, reaching $6.60. The company’s stock had a trading volume of 14,299 shares, compared to its average volume of 12,616. Cryo-Cell International has a 12 month low of $4.99 and a 12 month high of $9.50. The company has a market capitalization of $53.20 million, a P/E ratio of -6.23 and a beta of 0.53.

Institutional Investors Weigh In On Cryo-Cell International

Several institutional investors and hedge funds have recently bought and sold shares of CCEL. Rowlandmiller & PARTNERS.ADV bought a new position in shares of Cryo-Cell International in the 4th quarter valued at $107,000. CreativeOne Wealth LLC acquired a new position in Cryo-Cell International during the fourth quarter worth about $113,000. Heron Bay Capital Management bought a new position in shares of Cryo-Cell International in the fourth quarter worth about $235,000. Northern Trust Corp boosted its stake in shares of Cryo-Cell International by 78.2% in the 4th quarter. Northern Trust Corp now owns 38,902 shares of the company’s stock valued at $288,000 after purchasing an additional 17,066 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in Cryo-Cell International by 68.5% during the 3rd quarter. Geode Capital Management LLC now owns 39,860 shares of the company’s stock worth $254,000 after purchasing an additional 16,203 shares in the last quarter. Institutional investors own 10.44% of the company’s stock.

Cryo-Cell International Company Profile

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.